Morton Jerrald R, EVP and President of IPS at RRX (Regal Rexnord Corporation), has demonstrated a clear selling bias in recent transactions, with $7.38 million in total sales outweighing $3.13 million in purchases across 33 reported trades. The activity is concentrated exclusively in RRX shares, with no diversification into other securities. February 2026 saw significant sell-side movement, including a $1.71 million disposition on February 9 alongside five smaller sales ranging from $252,328 to $716,717 the same day. These were accompanied by a $3.95 million transaction coded as a derivative transaction (F). The most recent activity on February 23, 2026, included an $89,902 sale, continuing the liquidation trend observed throughout the month.
Historical filings show smaller, periodic acquisitions through awards (A) between 2024 and 2025, typically valued under $2,200 per transaction, with occasional larger purchases like the $192,392 open market buy in February 2024. However, the overall pattern since early 2026 has shifted decisively toward divestment, with no buys recorded in the most recent filings. The transactions suggest a reduction in Morton’s RRX position, particularly through a combination of open market sales (S) and derivative-related dispositions (F), though the exact nature of these transactions isn’t specified beyond SEC codes. The absence of recent purchases contrasts with earlier years when smaller, routine awards contributed to position growth.
AI-assisted summary